Fiji vs Niger: Antiretroviral therapy coverage for PMTCT
Fiji
57.0%
in 2024
Niger
63.0%
in 2024
Fiji rank
63rd
Niger rank
60th
Antiretroviral therapy coverage for PMTCT over time
- Fiji
- Niger
How they compare
Niger currently reports 63.0% against 57.0% in Fiji, a difference of 6.0%.
That makes Niger's figure about 1.1 times Fiji's.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Niger ahead.
Fiji ranks 63rd and Niger ranks 60th of 84 countries.
Across the 3 decades both report, Fiji averaged higher in 2 and Niger in 1.
Head to head by decade
| Decade | Fiji | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.4% | 4.7% | 21.7% | Fiji |
| 2010s | 71.6% | 56.3% | 15.3% | Fiji |
| 2020s | 31.0% | 42.6% | 11.6% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Fiji or Niger?
- Niger, at 63.0% against 57.0% in Fiji as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Fiji and Niger?
- 6.0%, with Niger ahead.
- How many years of comparable data are there for Fiji and Niger?
- 25 years are reported by both, from 2000 to 2024.
- How do Fiji and Niger rank globally for antiretroviral therapy coverage for pmtct?
- Fiji ranks 63rd and Niger ranks 60th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).